Page last updated: 2024-10-22

aminoglutethimide and Osteoporosis

aminoglutethimide has been researched along with Osteoporosis in 1 studies

Aminoglutethimide: An aromatase inhibitor that is used in the treatment of advanced BREAST CANCER.
aminoglutethimide : A dicarboximide that is a six-membered cyclic compound having ethyl and 4-aminophenyl substituents at the 3-position.

Osteoporosis: Reduction of bone mass without alteration in the composition of bone, leading to fractures. Primary osteoporosis can be of two major types: postmenopausal osteoporosis (OSTEOPOROSIS, POSTMENOPAUSAL) and age-related or senile osteoporosis.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Miki, Y1
Suzuki, T1
Hatori, M1
Igarashi, K1
Aisaki, KI1
Kanno, J1
Nakamura, Y1
Uzuki, M1
Sawai, T1
Sasano, H1

Other Studies

1 other study available for aminoglutethimide and Osteoporosis

ArticleYear
Effects of aromatase inhibitors on human osteoblast and osteoblast-like cells: a possible androgenic bone protective effects induced by exemestane.
    Bone, 2007, Volume: 40, Issue:4

    Topics: Alkaline Phosphatase; Aminoglutethimide; Androstadienes; Aromatase Inhibitors; Base Sequence; Cell L

2007